Switching Between Medications

Maybe your current medication isn’t giving you the results you expected. Maybe the side effects never settled down. Maybe your insurance changed and now your medication costs three times what it did last month. Or maybe you’ve been on a compounded version and you’re ready — or being told — to switch to a brand-name product.

Whatever the reason, if you’re thinking about switching GLP-1 medications, you’re not in unusual territory. This happens all the time. Providers adjust, patients switch, and the process is well-understood. It’s not starting over — it’s recalibrating.

Here’s what this page covers: the common reasons people switch, how the transition actually works for different scenarios, what to expect in the weeks after, and the one switch that trips people up more than any other. This is a conversation you’ll have with your provider — not something to figure out on your own — but understanding how it works puts you in a better position for that conversation.

---

Why People Switch

There’s no single reason people change GLP-1 medications. In practice, it usually comes down to one of these:

---

General Switching Principles

Here’s the reassuring part: switching between GLP-1 medications is straightforward. There’s no formal “washout period” required — that’s a term for waiting time between stopping one medication and starting another, used when drugs might interact or overlap. GLP-1 medications don’t need one.[1][2]

The general approach is simple: you take your first dose of the new medication when your next dose of the old one would have been due. If you were taking a weekly injection every Saturday, you take the new medication the following Saturday. If you were on a daily pill, you start the new pill the next morning.

Your provider handles the specifics — which dose to start at, how quickly to titrate, and whether any adjustments are needed based on your situation. But the underlying principle is consistent: one replaces the other, no gap required.

---

The Specific Scenarios

Not all switches are created equal. The dose you start at on the new medication depends entirely on what you’re switching from and what you’re switching to.

Semaglutide to Tirzepatide — The Switch That Matters Most

This is the one that catches people off guard, so let’s be clear about it: if you’re switching from semaglutide to tirzepatide, you start at the lowest dose (2.5mg) regardless of what semaglutide dose you were on. Even if you were on the maximum dose of Wegovy. Even if you’ve been on semaglutide for two years.[3]

Here’s why. Tirzepatide isn’t just “another GLP-1 medication.” It’s a dual agonist — it activates both GLP-1 receptors and GIP receptors (a different hormone system involved in metabolism and appetite). Semaglutide only activates GLP-1 receptors. Your body has tolerance to the GLP-1 effects from your time on semaglutide, but it has zero tolerance to the GIP effects. Those are pharmacologically distinct pathways. Cross-tolerance doesn’t apply here.

Starting at 2.5mg isn’t a setback. It’s protecting you from GI side effects that could be significant if you jumped to a higher dose. Even at that starting dose, the data is encouraging — a 151-patient study found that people switching from a GLP-1 to tirzepatide 5mg (one step above the starting dose) lost an additional 2.15kg and saw their HbA1c (a measure of average blood sugar over 2-3 months) drop by 0.43% within just 12 weeks. Only 13.2% developed GI side effects, and most were mild. Just 2% discontinued treatment.[3]

Compounded to Brand-Name

This switch is becoming more common as the FDA tightens oversight of compounded GLP-1 products. If you’ve been taking a compounded version of semaglutide or tirzepatide, the recommendation is clear: start at the lowest brand-name dose regardless of what dose you were on with the compounded product.[6]

The reason isn’t complicated. Compounded medications use different salt forms (compounded semaglutide is typically made with semaglutide sodium, which is a different chemical form than the semaglutide base used in Ozempic and Wegovy), different concentrations, and different manufacturing processes. There’s no reliable way to convert a compounded dose to a brand-name equivalent because the products aren’t standardized the same way. What was labeled as “1mg” from a compounding pharmacy may not deliver the same amount of active drug as 1mg from the brand-name manufacturer.

---

What to Expect After Switching

Even when the switch is straightforward, your body notices the change. Here’s what most people experience:

---

Making the Decision

Switching medications is a medical decision, not a DIY project. Even if the switch seems straightforward — same molecule, different brand — your provider needs to be involved. They’ll consider your current dose, your response history, your side effect profile, your insurance situation, and any other medications you’re taking before recommending a plan.

That said, don’t be afraid to bring this conversation to your provider. If your current medication isn’t working well enough, if the side effects aren’t manageable, if you’ve seen the tirzepatide head-to-head data and want to explore it — those are all legitimate reasons to ask. Providers expect these conversations. Switching GLP-1 medications is one of the most common adjustments in this space.

---

The Bottom Line

Switching between GLP-1 medications is common, well-studied, and usually goes smoothly with the right guidance. The key is working with your provider to match the transition to your specific situation — not guessing at doses or timing on your own.

Whether you’re changing because of results, side effects, insurance, cost, or curiosity about a different option, the process is manageable. You’re not starting from zero. You’re building on what your body has already learned, with a medication that might be a better fit.

Bring the data. Ask the questions. Let your provider map the transition. That’s how switches go well.

---